Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Eli Lilly
NYSE:LLY Community
1
Narratives
written by author
0
Comments
on narratives written by author
398
Fair Values set
on narratives written by author
Create a narrative
Eli Lilly
Popular
Undervalued
Overvalued
Eli Lilly
AN
Analyst Price Target
Consensus Narrative from 26 Analysts
Manufacturing Expansion And OpenAI Partnership Will Shape Future Prospects
Key Takeaways The expansion of manufacturing capability and a strong pipeline position Eli Lilly for potential revenue growth through increased demand and new product launches. Strategic acquisitions and collaborations, alongside shareholder-focused initiatives like share repurchases, indicate confidence in driving future revenue and earnings growth.
View narrative
US$1.01k
FV
17.1% undervalued
intrinsic discount
22.51%
Revenue growth p.a.
Set as Fair Value
6
users have liked this narrative
0
users have commented on this narrative
103
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
LLY
Eli Lilly
Your Fair Value
US$
Current Price
US$842.57
34.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-86m
92b
2015
2018
2021
2024
2025
2027
2030
Revenue US$91.7b
Earnings US$21.6b
Advanced
Set as Fair Value